Prostate Cancer Coverage from Every Angle

Published Medical Literature

Enzalutamide/ADT in Metastatic Hormone-Sensitive Prostate Cancer: ARCHES Trial
Should Stereotactic Body Radiation Therapy Be Standard Option in Localized Prostate Cancer?
Does Radical Prostatectomy Affect Sexual Interest and Satisfaction?
Cardiovascular Effects of Androgen-Deprivation Therapy in Prostate Cancer
Ultrahypofractionation Versus Conventional Fractionation in Prostate Cancer
Including Pelvic Lymph Nodes in Radiation Fields for Advanced Prostate Cancer: Update on Toxicity
Preventing Skeletal Fractures in Patients Treated for Metastatic Prostate Cancer
World Trade Center First Responders: Cause of Increased Risk of Prostate Cancer Explored
Can Repeated PSA Screening Reduce Prostate Cancer Mortality?
Inguinal Hernia After Minimally Invasive Radical Prostatectomy
LATITUDE Trial: Final Survival Data on Abiraterone Acetate and Prednisone Plus ADT
Radiotherapy After Prostatectomy: Updated Joint Clinical Guidance by ASTRO and AUA
Adding Docetaxel to Standard Treatment in High-Risk Prostate Cancer
Is There an Association Between Black Race and Mortality From Prostate Cancer?
Neoadjuvant Hormone Therapy Before Prostatectomy in Locally Advanced Prostate Cancer
Study Finds Docetaxel May Benefit Some Patients With Prostate Cancer
Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis
AR-V7 Assays and Treatment Outcomes in Castration-Resistant Prostate Cancer
Combining Approved Treatments in Metastatic Castration-Resistant Prostate Cancer
Viral Vector–Based Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Duration of ADT With Radiation After Prostatectomy Depends on Risk Factors
Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer
ARAMIS Trial: Darolutamide in Nonmetastatic Prostate Cancer
Risk of Dementia From Androgen-Deprivation Therapy for Prostate Cancer
LATITUDE Trial: Survival Benefit With Combination Therapy for Prostate Cancer
Lipid-Lowering Medication and Risk of Prostate Cancer
Active Surveillance vs. Radical Treatment of Prostate Cancer
Impact of Race on Survival in Metastatic Castration-Resistant Prostate Cancer
Androgen-Deprivation Therapy for Prostate Cancer: Managing Cardiovascular Risks
Health-Related Quality of Life in Men With Advanced Versus Localized Prostate Cancer
Computer-Simulated Study Suggests Enlarged Prostate May Actually Hinder Tumor Growth
Is Time to Biochemical Failure a Surrogate Endpoint in Locally Advanced Prostate Cancer?
Duration of Androgen Suppression and Zoledronic Acid in Locally Advanced Prostate Cancer
Does Apalutamide Negatively Impact Quality of Life in Nonmetastatic CRPC?
AUA Guideline Amendment for Castration-Resistant Prostate Cancer
Closer Look at Types of Prostatectomy and Quality of Life
Does Androgen-Deprivation Therapy Increase Risk of Heart Failure in Men With Prostate Cancer?
Can Tyrosine Kinase Inhibitors for CML Affect PSA Titers Unrelated to Prostatic Disease?
Assessing Combination of Osteoprotective Agents and Anticancer Drugs in Prostate Cancer
Early Research on Birabresib in Prostate Cancer and Other Solid Tumors
Noninvasive Diagnosis of Prostate Cancer Using Novel Imaging Technique
Long-Term Results With Hormonal Therapy Plus Radiotherapy in Prostate Cancer
Active Surveillance for Prostate Cancer: Are Patients Being Lost to Follow-up?
PSA Screening for Prostate Cancer: Does It Really Reduce Disease-Specific Mortality?
Coffee Consumption and Disease-Free Progression in Patients With Localized Prostate Cancer
Are Researchers Closer to Diagnosing Aggressive Prostate Cancer at an Early Stage?
Rebiopsy for Prostate Cancer: Can Some Men With Negative MRI Avoid It?
Does Enzalutamide Affect Metastasis-Free Survival in Men With Aggressive Prostate Cancer?
Can Hypofractionated Radiotherapy Improve Prostate Cancer Control?
Low Free Testosterone Concentration May Equal Low Prostate Cancer Risk
Survival Impact of Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Does Surgical Technique Affect Outcomes in Patients With Prostate Cancer?
New Prognostic Imaging Biomarker in Metastatic Prostate Cancer
Report Sheds Light on Trends in Prostate Cancer
Pharmacoeconomic Implications of Low-Dose Abiraterone in Castration-Resistant Prostate Cancer
Predictors of Urinary Function After Prostatectomy
Updated USPSTF Screening Guidelines for Prostate Cancer
Timing of Catheter Removal After Robot-Assisted Radical Prostatectomy
Clinical Associations of Luminal and Basal Subtyping in Prostate Cancer
ASCO Clinical Practice Guidelines for Metastatic Noncastrate Prostate Cancer
Robot-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer
Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer
After Disease Progression on Enzalutamide, Can Bipolar Androgen Therapy Make a Difference in Prostate Cancer?
SPARTAN Trial: Apalutamide in Nonmetastatic Prostate Cancer
Radiotherapy Versus Surgery for High-Risk Localized Prostate Cancer
Health-Related Quality of Life After Radical Prostatectomy

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.